Poxviral vaccine extends survival in prostate cancer
29 January 2010
| by Nicola Garrett
Patients with metastatic prostate cancer who received a vaccine of weakened poxviruses lived substantially longer than patients who received a placebo vaccine, researchers report....
Want to read complete article? Please Sign in or Register.